1-2 of 2
Li Long, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ET190L1-Artemis TM T Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and Refractory B-Cell Lymphoma

Zhitao Ying, MD PhD, Li Long, MD PhD, Hong Liu, MD PhD, Yuqin Song, MD PhD, David A. Rizzieri, MD, Bijan Nejadnik, MD, Jun Zhu, MD PhD, Cheng Liu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1689.
https://doi.org/10.1182/blood-2018-99-113163
Published: 2018
Journal Articles

Anti-CD19 ARTEMIS TM Therapy Drastically Reduces Cytokine Release without Compromising Efficacy Against Preclinical Lymphoma Models

Hong Liu, PhD, Li Long, MD PhD, Shon Green, PhD, Lucas H Horan, PhD, Bryan Zimdahl, PhD, Cheng Liu, PhD
Journal: Blood
Blood (2016) 128 (22): 3354.
https://doi.org/10.1182/blood.V128.22.3354.3354
Published: 2016